GlassScriptPhysician profile
John L Clayton
NPI 1326231937
$1,351.86
in general payments reported to CMS, 2019-2025
11 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $16.96 · 2021: $53.74 · 2023: $409 · 2024: $108 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $396.97 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $314.44 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Davol INC. | $251.15 | 2021-2025 | Phasix Mesh |
| Allergan, INC. | $164.96 | 2019-2020 | |
| Polynovo North America LLC | $97.92 | 2023-2025 | Novosorb Btm |
| Endo USA, INC. | $33.67 | 2024-2025 | Xiaflex |
| Sientra, INC. | $23.38 | 2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Solventum Corporation | $19.71 | 2025 | Activ.A.C. |
| Endo Pharmaceuticals INC. | $17.00 | 2024 | Xiaflex |
| Merck Sharp & Dohme LLC | $16.54 | 2021 | |
| Integra Lifesciences Corporation | $16.12 | 2025 | Integra, Omnigraft, Surgimend |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Clayton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.